Sunhawk Vision Biotech (ROCO:7759) LT-Debt-to-Total-Asset: 0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7759 Sunhawk Vision Biotech Inc ROCO:7759
12 GF Score
Price NT$31.40
! 1 Warning Sign
View Full Analysis

What is Sunhawk Vision Biotech LT-Debt-to-Total-Asset?

Sunhawk Vision Biotech ROCO:7759 +0.96% 12 LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus rates ROCO:7759 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Sunhawk Vision Biotech's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.00.

Sunhawk Vision Biotech's long-term debt to total assets ratio declined from Dec. 2024 (0.02) to Dec. 2025 (0.00). It may suggest that Sunhawk Vision Biotech is progressively becoming less dependent on debt to grow their business.

Sunhawk Vision Biotech  (ROCO:7759) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Sunhawk Vision Biotech LT-Debt-to-Total-Asset Related Terms

Sunhawk Vision Biotech LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Sunhawk Vision Biotech's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunhawk Vision Biotech LT-Debt-to-Total-Asset Chart

Sunhawk Vision Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.00 0.00 0.01 0.02 0.00

Sunhawk Vision Biotech Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only 0.01 0.03 0.02 0.01 0.00
ROCO:7759
12GF Score
Sunhawk Vision Biotech Inc ROCO:7759
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunhawk Vision Biotech LT-Debt-to-Total-Asset Calculation

Sunhawk Vision Biotech's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=1.407/498.806
=

Sunhawk Vision Biotech's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=1.407/498.806
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Sunhawk Vision Biotech (ROCO:7759) has a LT-Debt-to-Total-Asset of 0.00 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Sunhawk Vision Biotech and its competitors.
Is Sunhawk Vision Biotech's LT-Debt-to-Total-Asset too high?
Sunhawk Vision Biotech's current LT-Debt-to-Total-Asset is 0.00. Overall, Sunhawk Vision Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Sunhawk Vision Biotech's LT-Debt-to-Total-Asset compare to VRTX and REGN?
Sunhawk Vision Biotech's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Sunhawk Vision Biotech and its competitors. Sunhawk Vision Biotech's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunhawk Vision Biotech stock overvalued right now?
Sunhawk Vision Biotech (ROCO:7759) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Sunhawk Vision Biotech's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Sunhawk Vision Biotech (ROCO:7759), the current LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunhawk Vision Biotech Business Description

Address No. 6 Siwei 3rd Road, 17th Floor, Room A1, Lingya District, Kaohsiung, TWN
Sunhawk Vision Biotech Inc is a biotechnology company. The company is focused on developing new solutions for eye health and vision care. The company specializes in research and development of cutting-edge technologies aimed at treating and preventing ocular diseases. Their product portfolio includes products and services for curing dry eyes, myopia, and corneal erosion.
12GF Score

Get the complete analysis for ROCO:7759

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.40
Price